Content
Ecopipam is available now for context not to everyone but some eligible patients, this I found online. FDA Expanded Access Program (Oct 2025): The FDA authorized an EAP, providing a pathway for eligible patients (who failed existing D2-blockers like aripiprazole) to potentially get ecopipam while awaiting full approval. Ok can anyone confirm this, and can anyone get a hand on it and try it themself.
Themes
Anticipation & AvoidanceMeds & Substances
Subthemes
Overthinking & MonitoringMedication Inquiries
Codes (1)
dopamine_modulators_vmat2_inhibitors